Paul Kirchgraber

(Dr. Paul Kirchgraber)

Currently holds a position at Laboratory Corporation of America Holdings

Positions

Position Company Period
Executive Vice President and Chief Executive Officer - Covance Drug Development Laboratory Corporation of America Holdings Nov. 1, 2019 -
Paul Kirchgraber's trades of Laboratory Corporation of America Holdings's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-23 2023-05-19
S Sale
4,300 -24.9%
216.91
USD 932,707 		4,300 -24.9% 216.91 USD 932,707
2023-02-23 2023-02-21
S Sale
8,000 -46.9%
250.58
USD 2,004,675 		8,000 -46.9% 250.58 USD 2,004,675
2021-05-10 2021-05-06
S Sale
2,500 -24.2%
276.55
USD 691,375 		2,500 -24.2% 276.55 USD 691,375
2020-11-06 2020-11-04
S Sale
1,500 -16.3%
214.14
USD 321,204 		1,500 -16.3% 214.14 USD 321,204
// ... existing code ... // ... rest of the file ...